Evidence map›Paper›PMID 39735799›Full record

ArticleJournal of the West African College of Surgeons

Clear Cell Papillary Renal Cell Carcinoma: Case Series with Review of the Literature.

Anshima Singh, Ram Nawal Rao

Abstract readCase Reports
In one paragraph

Article in Journal of the West African College of Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anshima SinghDepartment of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Ram Nawal RaoDepartment of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell papillary renal cell carcinoma (CCPRCC) was included as a separate entity in the World Health Organisation classification of renal tumours in 2016. Immuno-histopathological and genetic characteristics are much known, but still, clinical features and long-term follow-up require more consolidated data. We report three cases of CCPRCC, detected in different clinical settings. The first case was co-incidentally diagnosed on routine imaging, in a follow-up case of open cystolithotripsy. The second case presented with haematuria under evaluation; and the third case presented with mild thrombocytopenia without anaemia or a positive Coombs test. All the cases revealed characteristic histopathological examination and immunohistochemistry. None of the patients showed tumour recurrence/metastases on follow-up. The study holds importance as it presents CCPRCC cases in different clinical scenarios, describes a rarely reported case of thrombocytopenia without associated anaemia/positive Coombs test, and emphasises the need to consider CCPRCC in relevant clinico-radiological settings and immuno-histopathological features, due to its indolent nature and consequently better prognosis.

Indexed as

(1) Clear cell papillary renal cell carcinoma (CCPRCC) can present in different clinical settings. (2) Urologists should consider CCPRCC in the differentials of radiologically small-sized RCCs, as more conservative management can be applied for it. (3) Pathologists should be mindful to rule in CCPRCC when seeing both the tubulo-papillary architecture and clear tumour cells on histopathological examination.Case reportclear cell papillary renal cell carcinomaclear cell renal cell carcinomahaematuriapapillary renal cell carcinomarenal cell carcinomathrombocytopenia

Identifiers

PMID39735799
PMCPMC11676007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.